COVID-19 updates: Classes in Chicago canceled for 4th day

Chicago Public Schools has been in talks with teachers over COVID-19 safety.

As the COVID-19 pandemic has swept the globe, more than 5.4 million people have died from the disease worldwide, including over 837,000 Americans, according to real-time data compiled by Johns Hopkins University's Center for Systems Science and Engineering.

About 62.5% of the population in the United States is fully vaccinated against COVID-19, according to data from the Centers for Disease Control and Prevention.


0

Mayo Clinic lays off 1% of staff for vaccine noncompliance

Mayo Clinic said it will lay off about 1% of its staff for failing to get at least one dose of the COVID-19 vaccine by a company deadline.

"While Mayo Clinic is saddened to lose valuable employees, we need to take all steps necessary to keep our patients, workforce, visitors and communities safe. If individuals released from employment choose to get vaccinated at a later date, the opportunity exists for them to apply and return to Mayo Clinic for future job openings," Mayo Clinic said in a statement to ABC.

Last October, Mayo Clinic had set a Jan. 3 deadline for all employees to get at least their first vaccine dose or face dismissal.

The health care organization said the number of staffers being let go was "comparable to what other health care organizations have experienced in implementing similar vaccine requirement programs."

Mayo Clinic employs about 73,000 people, according to its website.


FDA: Do not swab your throat with at-home COVID-19 tests

The FDA is warning people not to swab their throats as part of an at-home COVID-19 test.

In a statement obtained by ABC News, the FDA said that is not how the tests were designed and it could pose a safety concern.

"The FDA advises that COVID-19 tests should be used as authorized, including following their instructions for use regarding obtaining the sample for testing," the statement said.

Social media posts promoting at-home COVID-19 rapid test swabbing techniques claim that throat swabs collect a better sample. However, this hasn't been proven for currently authorized tests.

- ABC News' Sony Salzman


Biden doubles Pfizer antiviral pill purchase

President Joe Biden announced Tuesday afternoon that he was doubling the federal government's purchases of Pfizer's COVID-19 antiviral pill, from 10 million to 20 million treatment courses.

"They’re a gamechanger and have the potential to dramatically alter the impact of COVID-19, the impact it's had on this country and our people,” Biden said.

He also warned that those who remain unvaccinated "will die" during the ongoing omicron surge.

“So there's no excuse, no excuse, for anyone being unvaccinated,” Biden said.

-ABC News' Ben Gittleson


US now averaging nearly 500,000 daily cases, data shows

Data released by the Centers for Disease Control and Prevention from the weekend shows that the U.S. is now averaging nearly half a million new cases a day.

About a year ago, the U.S. was reporting an average of about 216,000 new cases a day. However, compared to last winter, hospital admissions and daily deaths are notably lower.

Over the last week, the U.S. reported more than 3.4 million new cases -- roughly averaging out to nearly six Americans testing positive every second.

-ABC News' Arielle Mitropoulos


FDA shortens Moderna booster waiting period to 5 months

The Food and Drug Administration authorized shortening the waiting period Friday for the Moderna COVID-19 vaccine booster shot to five months.

Previously, fully vaccinated adults had to wait six months before receiving a booster.

Recently, the FDA made similar changes to the Pfizer-BioNTech booster after early data showed the omicron variant was able to -- at least partially -- evade the protection offered by two doses.

“The country is in the middle of a wave of the highly contagious omicron variant, which spreads more rapidly than the original...virus and other variants that have emerged,” Dr Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement.

The statement continued, “Vaccination is our best defense against COVID-19, including the circulating variants, and shortening the length of time between completion of a primary series and a booster dose may help reduce waning immunity."